METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 OR 13249 MOLECULES

Details for Australian Patent Application No. 2003214920 (hide)

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/360,258 28.02.02 US; 60/364,476 15.03.02 US; 60/375,626 26.04.02 US; 60/386,494 06.06.02 US; 60/390,965 24.06.02 US; 60/392,480 28.06.02 US; 60/394,128 03.07.02 US; 60/399,783 31.07.02 US; 60/403,221 13.08.02 US; 60/407,045 30.08.02 US; 60/429,048 25.11.02 US; 60/354,333 04.02.02 US

25 September 2003 Application Open to Public Inspection

Published as AU-A-2003214920

21 October 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.